However, the cell lines used in these studies were, i.e., derived from embryonic kidney cells (HEK cells) or embryonic carcinoma cells (P19 cells), which may not entirely reflect the cardiomyocyte-specific microenvironment or physiological in vivo condition in which TMEM43 naturally acts. The gene discussed is TMEM43; the disease is embryonal carcinoma.